Background: Dissecting the molecular mechanism of muscle myosin function in vivo has proved difficult. Results: Transgenic fruit flies expressing mutant myosin and potential suppressor mutations suggest interacting amino acids. Conclusion: Communication between a relay domain residue and one in the converter is likely critical to myosin motor function. Significance: The transgenic system allows mapping of putative protein interactions essential for muscle contraction.
porting the contention that relay loop conformational changes occur as a result of rearrangements in the nucleotide pocket (7) (8) (9) . The reconfiguration of the relay loop at its interface with the converter repositions the converter and results in cocking of the adjacent lever arm (2, 3, 10) . Subsequent movement of the lever arm upon release of the products of ATP hydrolysis yields the myosin power stroke (11) (12) (13) . Although in vitro studies concur with this model of relay-converter interaction (for a review, see Ref. 1 ), the precise residues involved and the veracity of the interaction in muscle have yet to be tested. Here we take an integrative approach, using the Drosophila melanogaster model system, to discern whether communication between specific residues in the relay and converter domains is essential to myosin function, myofibril integrity, and muscle contraction.
Drosophila is particularly amenable to studying muscle myosin function in vivo. The single Mhc gene that encodes multiple isoforms via alternative splicing can be disabled in a musclespecific manner and replaced with engineered transgenes (for a review, see Ref. 14) . Furthermore, the indirect flight muscles can be programmed to express mutated myosins without concern as to the functional consequences because these muscles are not essential for viability (15, 16) . The indirect flight muscles are amenable to both ultrastructural and physiological analyses (17, 18) . In addition, myosin can be isolated from these muscles and used to correlate mutant phenotypes with biochemical and biophysical perturbations (14, 19) .
We previously showed that a mutation in converter residue Arg 759 results in significantly reduced myosin ATPase activity and in vitro actin sliding velocity and eliminates the enhanced tryptophan fluorescence indicative of relay loop reconfiguration and lever arm swing (20) . The R759E mutation also disrupts flight ability, reduces myofibril stability, and diminishes muscle fiber power generation (20, 21) . Our molecular modeling studies identified specific residues in the relay domain (Asn 509 and Asp 511 ) that are likely to interact with converter domain residue Arg 759 during the pre-and postpower stroke states (22) . Furthermore, relay residue Ile 508 can be crosslinked to converter residue Arg 759 in Dictyostelium discoideum myosin without severe functional defects (23) , suggesting that it can serve as a linker to the converter domain. Therefore, we hypothesized that abnormalities associated with mutated converter residue R759E arise in muscle as a result of disrupting the interaction between this residue and relay loop residues Ile 508 , Asn 509 , and/or Asp 511 . Here we used genetic suppression analysis to test this hypothesis. Our results define a putative relayconverter interaction (Asn 509 -Arg 759 ) that is critical for in vitro muscle myosin function as well as for normal muscle structure and contraction. Defining the molecular basis of relay-converter domain interaction in muscle provides insight into the mechanism of the myosin motor and its role in myofibril contraction and stability.
EXPERIMENTAL PROCEDURES
DNA Constructs-Using the pwMhcR759E myosin heavy chain genomic construct (20) and site-directed mutagenesis we constructed three transgenes: pwMhcI508K/R759E, pwMhcN509K/R759E, and pwMhcD511K/R759E. Each contains exon 11e encoding the mutant converter residue R759E in addition to newly mutated residues located in exon 9a of the relay domain. To produce these transgenes, the pwMhcR759E genomic construct was digested with EagI. The resulting 12.5-kb fragment was gel-isolated and subcloned into the pBluescriptKS EagI site (Stratagene, La Jolla, CA) to yield pwMhcR759E-3Ј. The remainder of the digested pwMhcR759E clone was religated to yield pwMhcR759E-5Ј. The pwMhcR759E-5Ј subclone was further digested with EcoRV. The resulting 2.9-kb EcoRV-digested fragment was gel-isolated and ligated into pBluescriptKS to yield R759E-RV. The R759E-RV subclone was then digested with SalI to produce a 0.8-kb SalI fragment, which was gel-isolated and ligated into pBlue-scriptKS to yield R759E-Sal. The R759E-Sal subclone contains exon 9a of the relay domain. The R759E-Sal subclone was used in conjunction with the QuikChange II kit (Stratagene) for in vitro mutagenesis to create all three individually mutagenized transgenes.
The in vitro mutagenesis exon-specific primer 5Ј-GAA-GGAGGGTAAGAACTGGGACTT-3Ј was used to create the I508K-Sal subclone (I508K codon change shown in bold). The in vitro mutagenesis exon-specific primer 5Ј-AGGGTATTA-AGTGGGACTTTATC-3Ј was used to create the N509K-Sal subclone (N509K codon change shown in bold). The in vitro mutagenesis exon-specific primer 5Ј-GGTATTAACTG-GAAGTTTATCGATTTC-3Ј was used to create the D511K-Sal subclone (D511K codon change shown in bold). Each of the three mutagenized subclones was sequenced to ensure the presence of the appropriate mutated nucleotides with no other changes. They were then individually digested with SalI. The 0.8-kb SalI fragment from each was gel-isolated and ligated back into the R759E-RV subclone to yield I508K/R759E-RV, N509K/R759E-RV, and D511K/R759E-RV subclones. Each of the three mutagenized RV subclones was digested with AvrII and SphI, which produced a 2.4-kb fragment. This fragment was gel-isolated and ligated into pwMhcR759E-5Ј. The resulting subclones (pwMhcI508K/R759E-5Ј, pwMhcN509K/R759E-5Ј, and pwMhcD511K/R759E-5Ј) were digested with EagI. The pwMhcR759E-3Ј subclone was digested with EagI, and the 12.5-kb fragment was gel-isolated and ligated into each of the three mutagenized subclones that had been digested with EagI to yield the transgenes pwMhcI508K/R759E, pwMhcN509K/ R759E, and pwMhcD511K/R759E. To ensure no changes had taken place during the cloning and plasmid isolation process, we sequenced the entire coding region, splice junctions, and cloning sites from an aliquot of the final transgene plasmids prior to P element-mediated transformation. P Element Transformation of Mhc Genes-BestGene, Inc. (Chino Hills, CA) utilized P element-mediated transformation (24) to produce transgenic lines for pwMhcI508K/ R759E, pwMhcN509K/R759E, and pwMhcD511K/R759E. 1200 embryos were injected for each transgene. Transgenes were mapped to chromosome locations using balancer chromosomes and standard genetic crosses. For pwMhcI508K/ R759E, 19 independent lines were obtained. Six mapped to the X chromosome, seven mapped to the second chromosome, and six mapped to the third chromosome. For pwMhcN509K/ R759E, eight independent lines were obtained. One mapped to the X chromosome, three mapped to the second chromosome, and four mapped to the third chromosome. For pwMhcD511K/ R759E, 13 independent lines were obtained. Five mapped to the second chromosome, and eight mapped to the third chromosome. Transgenic lines that mapped to the second chromosome were not used because the endogenous Mhc gene is located there, making it more difficult to cross into the Mhc 10null background (25) .
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)-We used RT-PCR to determine whether the inserted transgenes contained the expected nucleotide changes and whether their transcripts were spliced correctly compared with wild type. RNA was extracted from upper thoraces of 2-day-old adult female flies using the LiCl extraction method (26) . We then used the New England Biolabs Protoscript cDNA synthesis RT-PCR kit along with 0.5 g of total RNA and 3 mol of reverse primer. A forward primer specific to exon 2 (5Ј-TGGATCCCCGACGAGAAGGA-3Ј) was used with a reverse primer specific to exon 8 (5Ј-GTTCGTCACCC-AGGGCCGTA-3Ј) to generate a cDNA encoding the alternative exon 3 and 7 regions. The forward primer specific to exon 8 (5Ј-TCTGGATACCCAGCAGAAGCGT-3Ј) was used with a reverse primer specific to exon 12 (5Ј-GAGCTTCTTGAAGC-CCTTACGG-3Ј) to generate a cDNA encoding the alternative exon 9 and 11 regions. The forward primer specific to exon 14 (5Ј-CTCAAGCTCACCCAGGAGGCT-3Ј) was used with a reverse primer specific to exon 16 (5Ј-GGGTGACAGACGCT-GCTTGGT-3Ј) to generate a cDNA encoding the alternative exon 15 region. PCR was performed using 1 l of cDNA and 3 mol of each specific primer pair under the following conditions: 60 s at 94°C and then 30 cycles of 30 s at 94°C, 30 s at 55°C, and 2 min at 68°C. RT-PCR products were gel-isolated and subcloned using the Fermentas GeneJet PCR Cloning kit for sequencing. At least 10 independent clones for each RT-PCR were analyzed. The sequencing results confirmed that all cDNAs for each of the transgenic lines contained exons 3b, 7d, 9a, 11e, and 15a as is the case for the wild-type indirect flight muscle myosin transcripts (27, 28) . We also verified that the R759E mutation was present in exon 11e in all transgenic lines and that exon 9a contained the I508K, N509K, or D511K mutation as expected.
Myosin Expression Levels-Transgenic lines were crossed into the Mhc 10 background, and expression levels were determined by SDS-polyacrylamide gel electrophoresis as described previously (29) . Six dissected upper thoraces from 2-day-old female transgenic flies were homogenized in 60 l of SDS gel buffer. Eight microliters of homogenized sample was loaded on a 9% polyacrylamide gel. Each transgenic line was examined at least five times, each time with a newly prepared sample. Coomassie Blue-stained gels were digitally scanned using an Epson Expression 636 flatbed scanner. Protein accumulation was determined by NIH Image software using a myosin to actin ratio that was normalized to the ratio found in wild-type flies.
Flight Assay-Each transgenic line was assayed for flight ability. The flight assay determines whether a fly is capable of flying upward (U), horizontally (H), downward (D), or not at all (N) as described previously (30, 31) . All flight assays were performed on 2-day-old and 1-week-old adult female flies at 22°C with at least 100 flies for each line. The flight index was calculated as 6U/T ϩ 4H/T ϩ 2D/T ϩ 0N/T where T is the total number of flies tested (32) .
Myosin Isolation-Dorsolongitudinal indirect flight muscles from 180 -200 transgenic flies were removed by microscopic dissection. Myosin purification was carried out at 4°C essentially as described previously (19, 20, 33) . Briefly, dissected fibers were combined into a 1.5-ml microcentrifuge tube containing 1 ml of York modified glycerol (20 mM potassium phosphate, pH 7.0, 2 mM MgCl 2 , 1 mM EGTA, 20 mM DTT, and a protease inhibitor mixture). Tissue was centrifuged at 8500 ϫ g in a Sorvall Microspin 24S centrifuge for 5 min at 4°C. Pellets were resuspended in 1 ml of York modified glycerol containing 2% (v/v) reduced Triton X-100 and incubated for 30 min on ice. After centrifugation for 5 min (8500 ϫ g), the permeabilized fibers were washed free of detergent and glycerol by briefly suspending them in 1 ml of York modified glycerol without glycerol followed by centrifugation at 8500 ϫ g. The fiber pellets were resuspended in 82 l of high salt myosin extraction buffer (1 M KCl, 50 mM potassium phosphate, pH 6.8, 5 mM MgCl 2 , 0.5 mM EGTA, 10 mM sodium pyrophosphate, 20 mM DTT, and a protease inhibitor mixture) and incubated on ice for 15 min to extract myosin. High salt-insoluble material was removed by centrifugation for 5 min at 8500 ϫ g. The high salt extract was then diluted 25-fold with nano-H 2 O containing 10 mM DTT to an ionic strength of 40 mM, and myosin was allowed to precipitate overnight at 4°C. The precipitant was centrifuged using a Beckman TLA 100.3 rotor for 30 min at 100,000 ϫ g. The protein pellet was immediately resuspended in 13.5 l of wash buffer (2.4 M KCl, 100 mM histidine, pH 6.8, 0.5 mM EGTA, and 20 mM DTT) and placed on ice. After 30 min, the solution was slowly diluted 8-fold (with nano-H 2 O containing 10 mM DTT) to 0.3 M KCl for precipitation of residual actomyosin. After centrifugation at 60,000 ϫ g for 30 min, the supernatant was diluted 10-fold with nano-H 2 O containing 10 mM DTT and incubated on ice for 1 h to precipitate the purified myosin. After centrifugation at 100,000 ϫ g for 30 min, the purified myosin pellet was dissolved in myosin storage buffer (0.5 M KCl, 20 mM MOPS, pH 7.0, 2 mM MgCl 2 , and 20 mM DTT). The myosin concentration was determined by measuring the absorption at 280 nm as described previously (19, 20, 33) . Purified myosin was immediately used for ATPase and in vitro motility assays.
G-and F-actin Preparation-G-actin was isolated from acetone powder of chicken skeletal muscle as described previously (19, 20, 33) . After multiple cycles of polymerization-depolymerization, soluble G-actin was obtained after dialysis against 2 mM Tris-Cl, pH 8, 0.2 mM ATP, 2 mM CaCl 2 , and 1 mM DTT. It was quantified spectrophotometrically using an extinction coefficient of 0.62 cm Ϫ1 (A 310 nm -A 290 nm ) for 1 mg of actin ml Ϫ1 . To obtain a G-actin solution of ϳ30 M, the G-actin solution was concentrated using a Millipore Biomax-5 filter. F-actin was prepared by adding 1 volume of 10ϫ polymerization buffer (50 mM Tris-Cl, pH 8, 0.5 M KCl, 20 mM MgCl 2 , and 10 mM ATP) to 9 volumes of G-actin. Actin was stored on ice at 4°C and used within 1 month of preparation.
Steady-state ATPase Activity-ATPase activities of myosin were determined using [␥-32 P]ATP as described previously in detail (19, 20, 33) . Briefly, 2 g of freshly prepared myosin was added to Ca-ATPase buffer (10 mM imidazole, pH 6.0, 0.1 M KCl, and 10 mM CaCl 2 ) for Ca-ATPase. Ca-ATPase activity of myosin samples was initiated at 25°C by addition of [␥-32 P]ATP. The reaction was quenched following incubation for 15 min by adding 1.8 M HClO 4 . Extraction and scintillation counting were essentially as described previously (19) . Basal Mg-ATPase was carried out essentially as for Ca-ATPase except using Mg-ATPase buffer (10 mM imidazole, pH 6.0, 20 mM KCl, 2 mM MgCl 2 , 0.1 mM CaCl 2 , and 1 mM [␥-32 P]ATP). Actin-stimulated Mg-ATPase was assessed in Mg-ATPase buffer in the presence of increasing concentrations of F-actin (0.1-2 M). After 30 min, the reaction was quenched using 1.8 N HClO 4 . Basal Mg-ATPase activities obtained in the absence of actin were subtracted from all data points. Actin-activated V max and K m values for actin were obtained by fitting all data points from several preparations of wild-type and mutant myosin with the Michaelis-Menten equation using SigmaPlot. Catalytic efficiencies of the control, mutant, and suppressor myosins were determined from the V max /K m ratio as described previously (34, 35) . Values were averaged to give mean Ϯ S.D. Assessments of statistical significance of differences for Ca-ATPase, Mg-ATPase, V max , K m , and catalytic efficiency among I508K/R759E, N509K/R759E, D511K/R759E, and wild-type indirect flight muscle isoform (IFI), 2 or R759E myosin were carried out using Student's t tests.
In Vitro Motility-In vitro actin sliding velocity assays and analysis of captured video sequences were performed as described previously (19, 20, 33) . At least five sets of assays were carried out for each myosin studied. Assessments of statistical significance of differences of actin sliding velocity among I508K/R759E, N509K/R759E, D511K/R759E, and wild-type myosin were carried out using Student's t tests.
Electron Microscopy-To determine the effects of transgene expression on indirect flight muscle myofibril assembly and stability, we used transmission electron microscopy as described previously (36) . Transverse and longitudinal thin sections were taken from pupae, 2-h-old adults, 2-day-old adults, and 1-week-old adults and examined on a Tecnai 12 transmission electron microscope. We examined thoraces from at least three different flies at each stage for each transgenic line.
Protein Structure Modeling-Protein structure analysis was performed using the scallop muscle myosin II crystal structures as templates in the prepower stroke state (Protein Data Bank code 1qvi) (37) and the actin-detached internally uncoupled postpower stroke state (Protein Data Bank code 1kk8) (38) . The entire myosin S1 amino acid sequence for wild-type IFI, R759E, or each of the putative compensatory mutants (I508K/R759E, N509K/R759E, and D511K/R759E) was replaced into the scallop myosin S1 backbone. The SWISS-MODEL homology modeling server was used (39) with the coordinates of the scallop myosin II along with the amino acid sequence of Drosophila indirect flight muscle myosin S1. Structures were viewed using PyMOL (Schrödinger, LLC, New York, NY). To simplify comparisons, the chicken skeletal muscle myosin numbering system was used for all residue numbers (40) .
RESULTS

Putative Interactions between Myosin Converter Domain Residue Arg 759 and Residues in the Relay Domain-Mutation
R759E in the myosin converter domain results in biochemical and biophysical defects as well as aberrant muscle structural and physiological properties (20, 21) . The central portion of the converter domain is encoded by exon 11e in indirect flight muscle ( Fig. 1A, green) , and the converter interfaces with the exon 9a-encoded relay domain ( Fig. 1A , blue). Molecular modeling indicated that residues 508 -511 in the relay loop are located near the converter residue 759 (20) and defined weak and strong interactions of residues 509 and 511 during the rearrangements of the relay loop that are affiliated with the mechanochemical cycle (22) . Furthermore, Ile 508 can be cross-linked to Arg 759 in Dictyostelium non-muscle myosin II when they are each substituted by cysteine (23) . Therefore, we hypothesized that specific amino acids in the relay domain interact with converter residue 759 and that second site mutations in the relay FIGURE 1. Location of the relay and converter domains of myosin and potential relay residues that interact with converter residue Arg 759 . A, crystal structure of Drosophila indirect flight muscle myosin modeled using scallop myosin S1 in the prepower stroke state (Protein Data Bank code 1qvi) as a template. The relay domain is shown in blue and corresponds to amino acids 472-528. The central portion of the converter domain is shown in green and corresponds to amino acids 725-764. B, amino acid residues in the relay domain that potentially interact with the Arg 759 residue (green) in the converter domain are shown in the prepower stroke state (Protein Data Bank code 1qvi) (37) . Relay domain residues are Ile 508 (light blue), Asn 509 (red), and Asp 511 (gray). Ile 508 and Asn 509 residues are in close proximity to converter residue Arg 759 , whereas Asp 511 is more distant. Distances given are those between the donor hydrogen atom (not shown) and acceptor oxygen. C, amino acid residues in the relay domain that potentially interact with converter residue Arg 759 (green) are shown in the actin-detached internally uncoupled postpower stroke state (Protein Data Bank code 1kk8) (38) . Relay domain residues are Ile 508 (light blue), Asn 509 (red), and Asp 511 (gray). All three are in close proximity to the Arg 759 converter residue. For Asp 511 , there is a stronger potential to interact with Arg 759 in the postpower stroke state compared with the prepower stroke state (B). D, amino acids encoded by alternative exons 9a and 11e. Mutagenized amino acids I508K, N509K, D511K (exon 9a), and R759E (exon 11e) are underlined. The chicken skeletal muscle myosin numbering system was used for all residue numbers (40) .
residues may suppress the defects associated with converter mutation R759E.
To examine interactions among the relay and converter residues in more detail, we used the scallop muscle myosin II crystal structure in the prepower stroke ( Fig. 1B ) and the actindetached internally uncoupled postpower stroke (Fig. 1C ) states as structural templates in conjunction with the Drosophila indirect flight muscle myosin sequence. Molecular modeling using the SWISS-MODEL homology modeling server and PyMOL suggests that Arg 759 could interact with Ile 508 by hydrogen bonding, particularly in the prepower stroke state where the atomic distance is predicted to be 4.2 Å (Fig. 1B) . Polar residue Asn 509 is predicted to interact with Arg 759 by hydrogen bonding, particularly in the postpower stroke state (2.3 Å; Fig. 1C ). Although negatively charged residue Asp 511 might be envisioned to interact with positively charged Arg 759 to form a salt bridge during the postpower stroke state (Fig. 1C) , direct interaction is not predicted based upon the crystal structures studied. The identified residues are shown in context of their surrounding sequence in Fig. 1D . Note that Ile 508 and Arg 759 are encoded by all alternative versions of exon 9 and exon 11, respectively. Arg 759 is present in all versions of the converter. However, residues 509 and 511 vary among the three exon 9-encoded regions (41) . This suggests that alternative versions of these residues may modulate relay-converter interaction (22) .
Production and Verification of I508K/R759E, N509K/R759E, and D511K/R759E Transgenic Lines-We generated three putative compensatory mutations, I508K, N509K, and D511K, by in vitro mutagenesis of exon 9a and insertion of the mutant DNA into the existing R759E construct (20) . Following P element-mediated germ line transformation, three independent lines carrying each construct were brought into the Mhc 10 indirect flight muscle myosin-null background (25) . Two independent lines from each transgene were studied in detail, and these are listed in Table 1 .
In the Drosophila Mhc gene, there are six alternative exon sets, exons 3, 7, 9, 11, and 15 with exon 18 either included or excluded (27) . Using RT-PCR, we verified correct exon usage for each of the three transgenic lines (see "Experimental Procedures" for details). RT-PCR showed that each of the transgenes encodes mutation R759E (located in exon 11e) plus the appropriate second site mutation in exon 9a. Using SDS-polyacrylamide gel electrophoresis, we determined myosin expression levels relative to actin accumulation in upper thoraces, which are composed largely of indirect flight muscles. Levels of expression for each transgenic line were essentially identical to wild type ( Table 1) . Table 2 ). This suggests that the D511K mutation further disrupts flight ability compared with the original R759E mutation. We also examined the flight index for 1-week-old female flies. We previously reported that the flight index for the IFI wild-type control is 4.2 Ϯ 0.1 and that of pwMhcR759E is 0.05 Ϯ 0.01 (20) , indicating that flight ability is further depressed in the mutant during aging. In 1-week-old female pwMhcI508K/R759E flies, the flight index remains at 0.0, whereas that of pwMhcD511K/R759E decreases to the same flightless status ( Table 2 ). In contrast, the pwMhcN509K/ R759E flight index is 4.1 Ϯ 0.2, indicating that the N509K mutation continues to suppress R759E during aging. Thus, although Effects of Second Site Mutations on Basal and Actin-activated ATPase Activities-We previously reported that the Ca-ATPase, basal Mg-ATPase, and actin-stimulated Mg-ATPase (V max ) activities of R759E converter mutant myosin are significantly lower than those of the IFI wild-type control (20) . To explore the role of specific amino acid residues in the converter-relay domain interaction, we examined the effects of the putative relay loop compensatory mutations on ATPase activity (Table 3 and Fig. 2 ). I508K/R759E myosin showed no ATPase activity whatsoever. In contrast, Ca-ATPase, basal Mg-ATPase, and actin-stimulated Mg-ATPase activities of N509K/R759E myosin were significantly higher (p Ͻ 0.01) compared with those of R759E myosin (9.87 Ϯ 1.21 versus 3.96 Ϯ 0.99, 0.16 Ϯ 0.02 versus 0.10 Ϯ 0.04, and 0.98 Ϯ 0.15 versus 0.69 Ϯ 0.06 s Ϫ1 , respectively). However, K m of N509K/R759E was significantly lower (p Ͻ 0.001) compared with R759E (0.07 Ϯ 0.03 versus 0.27 Ϯ 0.08 M), indicating that the double mutant myosin possesses higher actin affinity in relation to Mg-ATPase activity compared with R759E. Note that in the absence of ATPase lev-els for actin concentrations below the fitted K m value for the double mutant this magnitude may be less precisely measured than for R759E. Interestingly, the Ca-ATPase activity of putative compensatory mutant N509K/R759E was not significantly different from the IFI control (9.87 Ϯ 1.21 versus 10.34 Ϯ 0.73 s Ϫ1 ). However, the basal Mg-ATPase and actin-stimulated Mg-ATPase values of N509K/R759E mutant myosin were significantly lower (p Ͻ 0.01) than the IFI control (0.16 Ϯ 0.02 versus 0.26 Ϯ 0.02 and 0.98 Ϯ 0.15 versus 1.86 Ϯ 0.33 s Ϫ1 , respectively). Furthermore, N509K/R759E myosin showed tighter actin affinity (K m ) compared with the IFI control (0.07 Ϯ 0.03 versus 0.26 Ϯ 0.10 M). The other putative compensatory mutant myosin, D511K/R759E, did not show enhancement in any ATPase parameter. In fact, actin-stimulated Mg-ATPase of D511K/R759E was significantly lower compared with the R759E mutant, and actin affinity (K m ) was enhanced (0.35 Ϯ 0.03 versus 0.69 Ϯ 0.06 s Ϫ1 and 0.09 Ϯ 0.03 versus 0.27 Ϯ 0.08 M, respectively). As shown in Fig. 2 and detailed in Table 3 , all the ATPase parameters of D511K/R759E myosin were significantly reduced compared with the IFI control. In summary, N509K/R759E mutant myosin showed significant enhancement of Ca-ATPase, Mg-ATPase, and actin-stimulated Mg-ATPase activities compared with R759E myosin, but the other two mutant myosins (I508K/R759E and D511K/ R759E) did not. This is borne out by examining the catalytic efficiency ( s Ϫ1 (given the caveat that the K m value was calculated to be below that for the minimal actin concentration used). Overall, our data suggest that the putative interaction of converter domain residue 759 with relay domain residue 509 is critically required for myosin ATPase activity.
Effects of Second Site Mutations on Flight Ability-We
Effects of Second Site Mutations on in Vitro Motility-We previously showed that the R759E converter domain mutation greatly reduces in vitro actin sliding velocity (20) . Here we tested the effects of the I508K/R759E, N509K/R759E, and D511K/R759E putative compensatory mutations on in vitro actin motility (Fig. 3 ). As expected from the lack of ATPase activity displayed by the I508K/R759E mutant myosin, this protein did not support actin sliding. In contrast, the actin sliding velocity of N509K/R759E myosin was significantly higher (p Ͻ 0.001) compared with R759E mutant myosin (5.68 Ϯ 0.63 ver- (Table 3) were subtracted from all data points, which were fit with the Michaelis-Menten equation to determine actin-stimulated ATPase (V max ) and actin affinity relative to ATPase (K m ). Calculated values and statistical significances are shown in Table 3 . Note that I508K/R759E yielded no ATPase activity. Control and R759E data are from Ref. 20 . Error bars represent S.D.
TABLE 3 Ca 2؉ -, Mg 2؉ -, and actin-stimulated Mg 2؉ -ATPase kinetics of control, mutant, and putative suppressor myosins
Six myosin preparations were assessed to calculate each reported mean value Ϯ S.D. ***, p Ͻ 0.001; **, p Ͻ 0.01; *, p Ͻ 0.05. The actin sliding velocity induced by D511K/R759E mutant myosin was significantly lower (p Ͻ 0.05) than that of converter mutant R759E myosin (3.57 Ϯ 0.81 versus 4.33 Ϯ 0.64 m s Ϫ1 ) and lower (p Ͻ 0.001) than IFI control myosin. Overall, the I508K and D511K myosin mutations further depressed actin sliding velocity of R759E myosin. However, mutant N509K/R759E myosin permitted ϳ85% of the actin sliding velocity compared with the IFI control, a significant improvement over the R759E mutant myosin (ϳ65%). This suggests that the putative interaction of converter domain residue 759 with relay domain residue 509 is important for driving in vitro actin motility.
Myosin
Ca-ATPase
Effects of Second Site Mutations on Muscle Structure-We compared the ultrastructure of indirect flight muscles expressing the R759E mutation alone and in the presence of each putative suppressor mutation. We previously showed that the R759E converter mutation results in nearly normal muscle structure in 2-h-old adults with subtle and then relatively severe degeneration in 2-day-old and 1-week-old adults, respectively (20) . In agreement with this observation, pwMhcR759E 2-day-old adult myofibrils show subtle disruptions in filament packing that result in occasional "cracks" in the lattice (Fig. 4A ). Sarcomeres display normal M-and Z-lines (Fig. 4C) . In contrast, pwMhcN509K/R759E 2-day-old adults show completely normal hexagonal packing of thick and thin filaments into sarcomeres (Fig. 4, B and D) . pwMhcR759E 1-week-old adult myofibrils (Fig. 4, E and G) have scattered Mand Z-line material with disruption of thick and thin filament regularity. In contrast, pwMhcN509K/R759E 1-week-old adults (Fig. 4, F and H) retain normal hexagonal packing of thick and thin filaments and show sarcomeric structure essentially identical to wild type. These results indicate that the N509K mutation suppresses the muscle structure defects seen in the R759E converter mutant, possibly as a result of the N509K relay loop mutation interacting with the R759E converter mutation in re-establishing myofibril structural stability.
The other two putative suppressors failed to rescue R759E myofibril structure and led to disruptions that were more severe than in pwMhcR759E. pwMhcI508K/R759E late stage pupae (Fig. 5, A and C) have disrupted myofibril morphology with filament assembly defects and poor alignment within sarcomeres. In contrast, pwMhcD511K/R759E late stage pupae (Fig. 5, B and D) have normal hexagonal packing of thick and thin filaments with sarcomeres that are essentially identical R759E (B) . B, transverse section from pwMhcN509K/R759E 2-day-old adult. Myofibril structure shows normal hexagonal packing of thick and think filaments and is essentially identical to wild-type 2-day-old adults (20) . C, longitudinal section from pwMhcR759E 2-day-old adult. Sarcomere structure appears similar to pwMhcN509K/R759E (D). D, longitudinal section from pwMhcR759E 2-dayold adult. Sarcomere structure appears normal with regular M-and Z-lines. E, transverse section from pwMhcR759E 1-week-old adult. Myofibril structure shows dramatic defects in hexagonal packing of thick and thin filaments. F, transverse section from pwMhcN509K/R759E 1-week-old adult. Myofibril structure has normal hexagonal packing of thick and think filaments and is essentially identical to wild type (20) . to wild type. Myofibril morphology in 2-h-old adult pwMhcI508K/R759E shows further degeneration (Fig. 5, E and  G) . Thick and thin filaments are scattered throughout the myofibril, and sarcomeres show poor filament alignment with gaps between the filaments. In contrast, pwMhcD511K/R759E 2-hold adults retain essentially wild-type muscle structure (Fig. 5, F  and H) . Two-day-old pwMhcI508K/R759E adult myofibril morphology (Fig. 5, I and K) is degraded similarly to that of 2-h-old adults (Fig. 5, E and G) . Two-day-old pwMhcD511K/ R759E adults (Fig. 5, J and L) show myofibrils with scattered Z-line material and disruption of thick and thin filament packing that is similar to pwMhcR759E 1-week-old adults (Fig. 4, E  and G) . In 1-week-old adult pwMhcI508K/R759E (Fig. 5, M and  O) , myofibril morphology further degenerates; thick and thin filaments are loosely scattered throughout the cytoplasm, and sarcomere morphology is highly aberrant. pwMhcD511K/ R759E 1-week-old adults (Fig. 5, N and P) show dense Z-line material scattered throughout the myofibril and disrupted sarcomere structure. Our results suggest that the I508K/R759E mutation severely affects myofibril assembly and stability compared with the single R759E converter mutation. In the case of D511K/R759E, the ultrastructure results are less severe than those of the I508K/R759E mutation but slightly more severe than those of the R759E mutation. Therefore, it appears that neither the I508K nor the D511K mutation re-established intra- molecular interactions that are required for normal myofibril morphology and stability.
Modeling Mutations in the Relay Domain along with the R759E Converter Mutation-To further assess potential interactions between the putative suppressor mutations and the converter R759E mutation, we used mutant versions of the Drosophila indirect flight muscle myosin sequence in conjunction with the scallop muscle myosin II crystal structure for computer-based molecular modeling. Fig. 6 shows prepower stroke (left panels) and actin-detached internally uncoupled postpower stroke (right panels) models for each of the double mutant combinations. Modeling suggests that I508K (light blue) can interact via hydrogen bonds with R759E (green), particularly in the postpower stroke state (Fig. 6A, right) , and that the predicted interaction of 4.2 Å is considerably more likely to occur than with the 6.9-Å distance predicted when Ile 508 is present. This enhanced interaction might be expected to suppress the R759E phenotype by re-establishing a tight linkage between the relay and converter because it is closer to the predicted 4.2-(prepower stroke) and 5.9-Å (postpower stroke) interactions present in the wild-type molecule (Fig. 1) . However, the I508K mutation dramatically worsens the R759E mutant phenotype. This may be due to the predicted 2.6-Å interaction of I508K with Ile 760 (magenta) in the postpower stroke state (Fig. 6A ) compared with the 5.5-Å distance predicted for the wild-type and R759E molecules. This interaction may distort the normal relay-converter interface and could be causative of the severe mutant phenotype. In the case of N509K, modeling suggests that this residue (red) interacts via hydrogen bonds with R759E (green), particularly in the postpower stroke state (3.7 Å; Fig. 6B, right) . However, this interaction is not different from that seen between Asn 509 and R759E and is not as close as the 2.3-Å distance predicted in wild type (Fig. 1) . The potential salt bridge between N509K and R759E is not predicted by the modeling program. However, rotation of the N509K side chain does put a terminal amino group well within the range for salt bridge formation, suggesting that the bridge may form to stabilize the interaction at some step of the cycle. For D511K, our modeling indicates that this mutant residue (gray) does not interact with R759E (green) in either the pre-or postpower stroke states with the closest potential hydrogen bond interaction predicted to be at 5.0 Å in the postpower stroke state (Fig. 6C ). It is important to note that the relayconverter interface undergoes considerable conformational change during the mechanochemical cycle and that the models represent only two snapshots of this process.
DISCUSSION
Here we investigated the communication pathway between the relay and converter domains in isolated muscle myosin and in myosin within the context of muscle fibers. We previously demonstrated that converter mutation R759E disrupts biochemical, biophysical, mechanical, and ultrastructural properties of Drosophila muscle myosin and indirect flight muscles (20, 21) . Molecular modeling showed that relay domain residues Ile 508 , Asn 509 , and Asp 511 potentially contact converter domain residue Arg 759 during the mechanochemical cycle ( Fig.  1 and Ref. 22 ). Therefore, we hypothesized that defects in R759E myosin arise as a result of disrupting the relay-converter interface. We used a novel genetic suppression approach in conjunction with the R759E mutant to demonstrate a putative interaction between converter domain residue 759 and relay FIGURE 6. Location of mutated residues in the relay domain and potential interactions with converter domain mutant residue R759E. The predicted location of specific mutated relay domain residues of Drosophila indirect flight muscle myosin are mapped onto the crystal structure of scallop myosin in the prepower stroke state (left; Protein Data Bank code 1qvi) (37) and the actin-detached internally uncoupled postpower stroke state (right; Protein Data Bank code 1kk8) (38) . A, in the postpower stroke state (right), I508K (light blue) is predicted to be located in closer proximity (4.2 Å) to the converter mutation R759E (green) than in the prepower stroke state (left). In the prepower stroke state, I508K is predicted to be distant from reside Ile 760 located in the converter domain (magenta). However, in the postpower stroke state, the I508K residue is predicted to be in close contact with Ile 760 (2.6 Å). B, in the postpower stroke state, N509K (red) is predicted to be in fairly close contact with the R759E converter mutation (3.7 Å). Mutating the N509K residue creates a change in charge that could result in the formation of a salt bridge between N509K and R759E if the side chain of the lysine residue is rotated. C, in the pre-and postpower stroke states, D511K (gray) is predicted to be fairly distant from the converter mutation R759E (with the closest interaction at 5.0 Å in the postpower stroke state). The potential salt bridge between Asp 511 and Arg 759 is not likely to occur. Distances given are those between the donor hydrogen atom (not shown) and acceptor oxygen. The chicken skeletal muscle myosin numbering system was used for all residue numbers (40) .
domain residue 509 and showed that the double mutation substantially improves the ATPase and actin sliding abilities of Drosophila muscle myosin. Furthermore, our integrative analysis established that this yields normal myofibril stability and indirect flight muscle function.
Results with Dictyostelium non-muscle myosin previously suggested that the relay domain maintains contact with the converter domain during the mechanochemical cycle (23) . This was shown by mutating the equivalents of Ile 508 in the relay domain and Arg 759 in the converter domain to cysteines. The cysteine residues were then cross-linked in vitro. This resulted in no apparent disruption in actin binding and basal ATPase activity; however, the actin-activated ATPase and K m were reduced by 29% (23) . Furthermore, an I508A mutation in the relay domain of Dictyostelium myosin abolishes myosin motor function both in vivo and in vitro (2) . This is presumably due to disrupted communication between the relay and converter domains. Our results graphically demonstrate the importance of residue Ile 508 for muscle myosin because we found that the I508K mutation in the presence of R759E eliminated both ATPase activity and in vitro motility. In addition, these mutations dramatically disrupted myofibril assembly (Fig. 5, A and  C) , which was only slightly affected by the R759E mutation alone (Fig. 4, A and C) . The presumed absence of mechanical force in I508K/R759E mutants leads to the observed flightless phenotype. The abnormal assembly of myofibrils displayed in muscles expressing I508K/R759E myosin coupled with the lack of enzymatic and mechanical function of the mutant myosin provides an important insight into myofibril assembly, i.e. that this process is dependent upon at least a partially functional relay-converter interface. This suggests that myosin crossbridges need to interact productively with actin-containing thin filaments for myofibril assembly to proceed normally. Indeed, we previously showed that "headless" myosin can assemble into thick filaments and that these filaments interdigitate with thin filaments but that normal myofibrillar structures cannot assemble in the absence of the myosin cross-bridge (42) . In contrast, myosins with reduced actomyosin interactions may permit normal myofibrillar assembly (31) .
The most dramatic aspect of our study is the rescue of flight ability observed when using the N509K mutation to suppress R759E ( Table 2 ). This was accompanied by rescue of myofibril assembly and stability (Fig. 4) as well as Ca-ATPase activity ( Table 3) . Although values for basal and actin-activated Mg-ATPase are not completely rescued, they are significantly improved compared with R759E (Table 3 and Fig. 2) . The nearly 4-fold increase in actin affinity (as measured by K m ) combined with the improved V max yields an enhanced catalytic efficiency (V max /K m ), which appears to be sufficient for rescuing normal in vivo muscle function. We observed a substantial rescue of in vitro actin sliding velocity as well, although values did not improve to wild-type levels (Fig. 3) , perhaps due to the increased actin affinity (Table 3 ). Molecular modeling using pre-and postpower stroke structures of scallop myosin did not predict formation of a salt bridge between N509K and R759E (Fig. 6B ). However, rotation of the side chain of N509K would permit formation of a stabilizing salt bridge as might occur during other stages of the mechanochemical cycle. A classical genetic interpretation of these data would argue that the suppression of the R759E mutation by N509K indicates that the interaction of the two residues occurs in the wild type, is disrupted by the R759E mutation, and is re-established by the N509K suppressor mutation. However, it is important to note that second site suppressors may establish amino acid relationships that do not exist in the native molecule. It is also possible that the N509K mutation enhances myosin function in the absence of interactions with the converter domain. We plan to directly examine relay-converter interactions by determining the structure of Drosophila myosin molecules at various stages of the mechanochemical cycle using x-ray crystallography in conjunction with myosin isolated from a novel Drosophila myosin expression system (43) .
In contrast to the striking effects of the I508K and N509K mutations on the R759E myosin phenotypes, the D511K mutation had only subtle consequences. There were minor reductions in flight ability, ATPase activities, and in vitro actin sliding velocity (Tables 2 and 3 and Figs. 2 and 3) . Given that molecular modeling did not predict interactions between the two mutated residues (Fig. 6C ), the lack of rescue is unsurprising and may represent additive effects of the two mutations.
It is interesting to note that residues 509 and 511 represent two of the five relay domain residues that vary among Drosophila muscle myosin isoforms (41) . Thus, these residues, particularly residue 509, are likely to serve as modulators of relayconverter interaction. Interestingly, residue 509 varies among human muscle myosin isoforms as well, with the superfast extraocular myosin having a glutamic acid at this position compared with threonine in slower forms, suggesting a tighter linkage to the basic residue at position 759 in the faster myosin (44) . We have shown that substitution of the entire relay domain of Drosophila IFI into an embryonic myosin isoform severely affects myosin function and myofibril stability (33) , whereas the insertion of the embryonic relay into IFI impairs power generation in isolated fibers (45) . It will be interesting to discern whether the two variable residues at the relay-converter interface play major roles in defining these functional properties. We are approaching this by mutating each residue individually to resemble that of the alternative isoform. Another potential use of this Drosophila system coupled to the genetic suppressor approach is to study the interactions of amino acid residues known to be critical for myosin-based diseases of skeletal and cardiac muscles. Putative interactions that are disrupted by such mutations can be mapped using molecular modeling or crystallography. These interactions can be tested using putative suppressor alleles that can be analyzed using the integrative system we describe here.
In conclusion, we used a unique in vivo genetic suppression approach and a multilevel analysis to demonstrate that one of three candidate amino acid residues in the relay domain of muscle myosin is a candidate for interacting with residue 759 of the converter domain. These interactions appear to be critical for myosin ATPase activity, in vitro sliding of actin filaments, indirect flight muscle myofibril stability, and the ability of adults to fly. Further disruption of the relay-converter domain interface, through its putative distortion by the I508K mutation, leads to complete absence of myosin ATPase activity and actin sliding as well as severe abnormalities in myofibril assembly and flight failure. Our study shows that specific interactions at the relay-converter interface likely are critical for normal muscle myosin performance as well as myofibril assembly and muscle function.
